Sequence heterogeneity in NS5A of hepatitis C virus gentypes 2a and 2b and clinical outcome of pegylated-Interferon/Ribavirin therapy
Sequence heterogeneity in NS5A of hepatitis C virus gentypes 2a and 2b and clinical outcome of pegylated-Interferon/Ribavirin therapy
复制标题
丙型肝炎病毒基因型 2a 和 2b NS5A 的序列异质性以及聚乙二醇化干扰素/利巴韦林治疗的临床结果
作者:
El-Shamy;A.;Shoji;I.;Kim S-R.;Ide;Y-H.;Imoto;S.;Deng;L.;Yoon;S.;Fujisawa;T.;Tani;S.;Yano;Y.;Seo;Y.;Azuma;T.;and Hotta;H